NCT01289249已完成不适用
Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, Rikshospitalet
Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- We will determine how many of the patients in our material that have plasma concentrations of meropenem above 8 mg/l for at least 40% and 75% of the time.
研究概览
简要总结
The object of the study is to investigate whether all included patients receive treatment that is effective against all bacteria that are defined as sensitive to meropenem with the current treatment regimen. Will the investigators findings motivate routine monitoring of plasma concentrations in children receiving meropenem? Up to 50 patients will be included in the study, and all participants are children.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 3 Months 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children aged from 3 months to 18 years that receive treatment with meropenem. Inclusion is independent of how long the patient has been receiving treatment. Children receiving other treatment (except hemodialysis)/other medications can be included.
排除标准
- •Children less than three months of age. Patients receiving hemodialysis. Lack of consent.
结局指标
主要结局
We will determine how many of the patients in our material that have plasma concentrations of meropenem above 8 mg/l for at least 40% and 75% of the time.
时间窗: 1 dosing interval (8 hours)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Meropenem and Piperacillin Plasma Concentrations During CRRTInfectionAntibioticRenal Replacement TherapyHemolysisSepsisNCT04203784Karolinska University Hospital135
Unknown
不适用
PK of Meropenem in Patients on Plasma ExchangeAutoimmune DiseasesNCT05042271Prince of Songkla University15
已完成
4 期
Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem TreatmentCentral Nervous System InfectionsNCT02506686Huashan Hospital82
已完成
4 期
Meropenem Dosage Strategy Based on PPK ModelLower Respiratory Tract InfectionNCT01944319Qingtao Zhou79
已完成
不适用
Therapeutic Drug Monitoring of Meropenem and Clinical Cure Assessment in Critically Ill Pediatric Patients: a Prospective Observational StudyCritically Ill Pediatric PatientsMeropenem, Therapeutic drug monitoring, Extended infusion, Intermittent bolus, Critically ill, PediatricTCTR20200901002Clinical pharmacokinetics and pharmacogenomics research unit72